|
|
Since its formation in 2002, Claritas has made investments in 37 companies, representing over $500 million of capital. Equity investments are venture in nature, either early stage or growth equity (what some consider late stage venture) and weighted primarily toward healthcare and technology sectors. Debt investments are structured as mezzanine capital for lower-middle market healthcare and business services companies with strong historical cash flows and revenues of between $2 million and $10 million. The investment professionals in the Claritas Capital debt team seek to provide mezzanine capital to lower-middle market companies with strong historical cash flows and revenues of $20 to $150 million. The investment team is skilled at underwriting debt for healthcare companies, business services companies, specialty retail and distribution, and, manufacturing. Claritas focuses its efforts on the Southern corridor of the U.S. and the Midwest. The firm's equity investment range is $2,000,000 to $5,000,000. Specialty Debt financings can range from $2,000,000 to $15,000,000. For venture, Claritas does not have a current interest in pursuing large bio-tech or life sciences investments. For mezzanine, the firm does not make investments in real estate, financial services, or high technology companies.
|
